MESOBLAST LIMITED

2.58%

$1.99

Market Cap $2.547B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

MEMPHASYS LIMITED

Many are concerned about global falling birthrates. This diverse stock has solutions. Here, then, one can’t afford to miss perusing what ASX-listed fertility tech healthcare smallcap Memphasys Ltd (ASX:MEM) can offer the world.

Latest Threads

Tag

Subject

MSB

banter and General Discussion

307 308 309

18:19

18K

6.8M

18:19

Last post Pazy1

18K

6.8M

MSB Biotech

MSB - a new dawn

44 45 46

18:04

2.7K

1.1M

18:04

Last post Mani86

2.7K

1.1M

MSB

Chart

6 7 8

16:46

446

192K

16:46

Last post WelshBuffett

446

192K

MSB

Ann: Mesoblast Option to Issue up to US$50m Convertible Notes

2 3

15:21

121

24K

15:21

Last post Showtime

121

24K

MSB

Back Pain trial - site increase

14:39

7.8K

14:39

Last post timmyjuly

7.8K

MSB

Shorts Closing

12:23

11K

12:23

Last post scorpiomo

11K

MSB

Ann: Proposed issue of securities - MSB

10:16

447

10:16

Last post

ASX News

447

MSB

Cell Therapy News/Articles

333 334 335

09:52

20K

8.5M

09:52

Last post csrwin

20K

8.5M

See All Discussions

Timeline

Proposed issue of securities - MSB
04 Sep 09:56	Share

Mesoblast Option to Issue up to US$50m Convertible Notes
04 Sep 09:45	Share

Becoming a substantial holder
29 Aug 18:39	Share

MSB Annual Financial Results and Operational Update
29 Aug 08:31	Share

Annual Financial Results Presentation
29 Aug 08:26	Share

Preliminary Final Report including Appendix 4E
29 Aug 08:23	Share

Mesoblast 2025 Full Year Financial Results Webcast
27 Aug 16:17	Share

Ceasing to be a substantial holder
25 Aug 14:34	Share

Becoming a substantial holder
29 Jul 19:26	Share

Ceasing to be a substantial holder
25 Jul 18:50	Share

Ceasing to be a substantial holder
25 Jul 08:17	Share

Becoming a substantial holder
23 Jul 08:14	Share

Ceasing to be a substantial holder
21 Jul 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
18 Jul 09:58	Share

Becoming a substantial holder
18 Jul 08:20	Share

Notification of cessation of securities - MSB
14 Jul 18:23	Share

Notification regarding unquoted securities - MSB
14 Jul 18:19	Share

Application for quotation of securities - MSB
14 Jul 18:14	Share

Notification regarding unquoted securities - MSB
14 Jul 18:08	Share

Ceasing to be a substantial holder
08 Jul 18:46	Share

Becoming a substantial holder
07 Jul 08:20	Share

Mesoblast and FDA Align on Key Items for Revascor BLA
01 Jul 09:49	Share

Ceasing to be a substantial holder
26 Jun 08:21	Share

Ceasing to be a substantial holder
18 Jun 08:19	Share

Becoming a substantial holder
17 Jun 08:23	Share

Ceasing to be a substantial holder
16 Jun 08:19	Share

Mesoblast Maintains Momentum with FDA
12 Jun 10:14	Share

Becoming a substantial holder
06 Jun 08:21	Share

Becoming a substantial holder
05 Jun 08:18	Share

Becoming a substantial holder
03 Jun 15:59	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.99		Change 0.050(2.58%)		Mkt cap ! $2.547B

Open	High	Low	Value	Volume
$1.92	$2.05	$1.92	$12.56M	6.352M

Buyers (Bids)

No.	Vol.	Price($)
1	2257	$1.99

Sellers (Offers)

Price($)	Vol.	No.
$1.99	197	1

View Market Depth

No.	Vol.	Price($)
1	2257	1.985
7	114214	1.980
3	16283	1.975
6	27903	1.970
1	10000	1.965

Price($)	Vol.	No.
1.990	197	1
2.000	1670	2
2.010	67798	5
2.020	1010	2
2.030	10000	1

Last trade - 16.18pm 04/09/2025 (20 minute delay)


Last $1.99		Change 0.050 ( 1.92 %)
Open	High	Low	Volume
$1.93	$2.04	$1.93	1177952
Last updated 15.59pm 04/09/2025 ?

MSB (ASX) Chart

MESOBLAST LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Mesoblast (ASX:MSB) flags strengthened heart function in latest trial results

28 Feb 2023 10:07 (AEDT)

Latest Articles

Mesoblast falls -10% on earnings report; -US$100M loss

Mesoblast had HotCopper users divided on whether the company's fortunes are anything to worry about based on the nature of a Friday webcast.

The market shrugged at Mesoblast's latest FDA win. Is it just another Droneshield?

Mesoblast (ASX:MSB) has revealed the US FDA has given its flagship drug a 7 year exclusivity period, blocking...

Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab

Mesoblast (ASX:MSB) has seen shares fall just shy of -3% heading into lunchtime trades despite apparent tariff relief.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News